Covered recipient · General Payments record
WILLIAM FABRICIUS
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$9,574.54
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,271.75 | 57 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $116.55 | 3 |
| EISAI INC. | $90.65 | 4 |
| Merck Sharp & Dohme Corporation | $85.40 | 3 |
| Acerta Pharma LLC | $80.49 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $78.20 | 3 |
| Incyte Corporation | $66.91 | 3 |
| GlaxoSmithKline, LLC. | $63.41 | 3 |
| Janssen Biotech, Inc. | $63.05 | 3 |
| Celgene Corporation | $58.13 | 3 |
| Genentech USA, Inc. | $53.29 | 2 |
| PFIZER INC. | $48.69 | 3 |
| SpringWorks Therapeutics, Inc. | $41.82 | 2 |
| ABBVIE INC. | $41.26 | 2 |
| Sumitomo Pharma America, Inc. | $40.52 | 2 |
| Daiichi Sankyo Inc. | $40.21 | 2 |
| SOBI, INC | $37.35 | 2 |
| ARRAY BIOPHARMA INC | $37.19 | 2 |
| BeiGene USA, Inc. | $26.39 | 1 |
| PharmaEssentia USA Corporation | $25.30 | 1 |
| Immunocore Limited | $24.78 | 1 |
| Agios Pharmaceuticals, Inc. | $23.78 | 1 |
| SERVIER PHARMACEUTICALS LLC | $23.48 | 1 |
| Gilead Sciences, Inc. | $21.40 | 1 |
| Lilly USA, LLC | $21.12 | 1 |
| Astellas Pharma US Inc | $20.10 | 1 |
| GENZYME CORPORATION | $18.67 | 1 |
| EMD Serono, Inc. | $16.28 | 1 |
| Rigel Pharmaceuticals, Inc. | $7.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.